Improving access to therapeutic clinical trials: a randomized controlled trial of GUIDE navigation and reimbursement - Top-Institutions - MDSpire

Improving access to therapeutic clinical trials: a randomized controlled trial of GUIDE navigation and reimbursement

  • By

  • Kristine A. Karvonen

  • Jean A. McDougall

  • Elizabeth A. Carosso

  • Tina Burrows

  • Solange H. Mecham

  • Chongzhi Di

  • Sarah D. Hohl

  • Elizabeth Stohr

  • Anne Devine

  • Hannah Linden

  • Ajay K. Gopal

  • Evan Y. Yu

  • Andrew J. Cowan

  • Jason A. Mendoza

  • June 16, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #3

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Oncology

  • #4

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, OH

    Key Differentiators

    • Oncology

Original Source(s)

Improving access to therapeutic clinical trials: a randomized controlled trial of GUIDE navigation and reimbursement

  • by Kristine A. Karvonen, Jean A. McDougall, Elizabeth A. Carosso, Tina Burrows, Solange H. Mecham, Chongzhi Di, Sarah D. Hohl, Elizabeth Stohr, Anne Devine, Hannah Linden, Ajay K. Gopal, Evan Y. Yu, Andrew J. Cowan, Jason A. Mendoza

  • June 16, 2026

Related Content

Editorial: Innate lymphoid cells in cancer: volume II

Case Report: Pediatric nasopharyngeal carcinoma masquerading as benign lymphadenopathy: diagnostic pitfalls in two cases

Case Report: KIF5B-ALK–rearranged renal cell carcinoma